488 related articles for article (PubMed ID: 11049763)
41. Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia.
Strålin K
Int J Antimicrob Agents; 2008 Jan; 31(1):3-11. PubMed ID: 17920819
[TBL] [Abstract][Full Text] [Related]
42. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures.
Waterer GW; Wunderink RG
Respir Med; 2001 Jan; 95(1):78-82. PubMed ID: 11207022
[TBL] [Abstract][Full Text] [Related]
43. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
[No Abstract] [Full Text] [Related]
44. Epidemiology of community-acquired pneumonia in children.
Yamazaki T; Murayama K; Ito A; Uehara S; Sasaki N
Pediatrics; 2005 Feb; 115(2):517; author reply 517. PubMed ID: 15687473
[No Abstract] [Full Text] [Related]
45. Classical and latent class analysis evaluation of sputum polymerase chain reaction and urine antigen testing for diagnosis of pneumococcal pneumonia in adults.
Butler JC; Bosshardt SC; Phelan M; Moroney SM; Tondella ML; Farley MM; Schuchat A; Fields BS
J Infect Dis; 2003 May; 187(9):1416-23. PubMed ID: 12717623
[TBL] [Abstract][Full Text] [Related]
46. Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia.
Endeman H; Schelfhout V; Voorn GP; van Velzen-Blad H; Grutters JC; Biesma DH
Scand J Infect Dis; 2008; 40(9):715-20. PubMed ID: 19086245
[TBL] [Abstract][Full Text] [Related]
47. Clinical features of community-acquired pneumonia treated at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W; Tantiwong P
Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):355-61. PubMed ID: 12236437
[TBL] [Abstract][Full Text] [Related]
48. Community-acquired pneumonia in the central desert and north-western tropics of Australia.
Rémond MG; Ralph AP; Brady SJ; Martin J; Tikoft E; Maguire GP
Intern Med J; 2010 Jan; 40(1):37-44. PubMed ID: 20561364
[TBL] [Abstract][Full Text] [Related]
49. Can sputum gram stain be used to predict lower respiratory tract infection and guide empiric antimicrobial treatment: Experience from a tertiary care hospital.
Gunasekaran J; Saksena R; Jain M; Gaind R
J Microbiol Methods; 2019 Nov; 166():105731. PubMed ID: 31629914
[TBL] [Abstract][Full Text] [Related]
50. Community-acquired Haemophilus influenzae pneumonia--New insights from the CAPNETZ study.
Forstner C; Rohde G; Rupp J; Schuette H; Ott SR; Hagel S; Harrison N; Thalhammer F; von Baum H; Suttorp N; Welte T; Pletz MW;
J Infect; 2016 May; 72(5):554-63. PubMed ID: 26940505
[TBL] [Abstract][Full Text] [Related]
51. Community acquired bacterial pneumonia: aetiology, laboratory detection and antibiotic susceptibility pattern.
Akter S; Shamsuzzaman SM; Jahan F
Malays J Pathol; 2014 Aug; 36(2):97-103. PubMed ID: 25194532
[TBL] [Abstract][Full Text] [Related]
52. [Initial empirical antibiotic treatment of community-acquired pneumonia].
Frías J; Gomis M; Prieto J; Mensa J; Bouza E; García-Rodríguez JA; Torres A; Dorca J; Zalacaín R; García de Lomas J
Rev Esp Quimioter; 1998 Sep; 11(3):255-61. PubMed ID: 9795313
[No Abstract] [Full Text] [Related]
53. Sputum specimens can be obtained from patients with community-acquired pneumonia in primary care.
Lagerström F; Fredlund H; Holmberg H
Scand J Prim Health Care; 2004 Jun; 22(2):83-6. PubMed ID: 15255486
[TBL] [Abstract][Full Text] [Related]
54. [Community acquired pneumonia].
Marrie TJ
Praxis (Bern 1994); 2001 May; 90(21):935-40. PubMed ID: 11512537
[No Abstract] [Full Text] [Related]
55. Blood cultures do not change management in hospitalized patients with community-acquired pneumonia.
Ramanujam P; Rathlev NK
Acad Emerg Med; 2006 Jul; 13(7):740-5. PubMed ID: 16766742
[TBL] [Abstract][Full Text] [Related]
56. Acute community-acquired pneumonia: current diagnosis and treatment.
Bryan CS
J S C Med Assoc; 2001 Jan; 97(1):19-26. PubMed ID: 11227252
[TBL] [Abstract][Full Text] [Related]
57. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
[TBL] [Abstract][Full Text] [Related]
58. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
Jover F; Cuadrado JM; Andreu L; Martínez S; Cañizares R; de la Tabla VO; Martin C; Roig P; Merino J
Eur J Intern Med; 2008 Jan; 19(1):15-21. PubMed ID: 18206596
[TBL] [Abstract][Full Text] [Related]
59. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
60. Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia.
Wu CL; Lee YL; Chang KM; Chang GC; King SL; Chiang CD; Niederman MS
Crit Care Med; 2003 Mar; 31(3):812-7. PubMed ID: 12626989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
